RecruitingNot ApplicableNCT06963736
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
Sponsor
Arizona State University
Enrollment
30 participants
Start Date
Aug 7, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.
Eligibility
Min Age: 26 Years
Inclusion Criteria11
- ≥26 years of age
- BMI ≥ 27 kg/m2\*; ≥25 kg/m2, if Asian (full or multiple race)\*\*
- Insufficiently active (per US National Guidelines for Physical Activity of 150 minutes of MVPA/Week)
- Reporting an average of ≥3 hours of recreational sedentary screen time (rSST) per day, that usually extends at least until 9:00pm.
- On a typical night, consumes calories (food and/or drink) after 8:00pm.
- Meet at least 2 criteria for metabolic syndrome
- Central adiposity: waist circumference \>40 inches (men); \>35 inches (women)
- Elevated blood pressure: SBP \>130 mmHg and/or DBP \>85 mmHg OR controlled with medication
- Low high density lipoprotein (HDL) cholesterol: \<40 mg/dL (men); \<50 mg/dL (women)
- Elevated triglycerides: \>150 mg/dL OR controlled with medication
- Elevated fasting glucose: ≥100 mg/dL OR controlled with medication
Exclusion Criteria20
- Conditions related to sleep disruption, including lactation, pregnancy, mid-night care providers, sleep disorders, severe sleep apnea
- History of hypoglycemia
- Pacemaker
- Caffeine consumption in excess and/or after 5pm (excess equals \>4 cups of coffee per day or equivalent)
- Involvement in other physical activity, diet, or weight loss programs/studies
- Weight change of 5% up or down in the last three months.
- Drug abuse
- THC use (smoking, edibles)
- Excessive alcohol use (for women, 8 or more drinks per week; for men, 15 or more drinks per week)
- Current smoker or user of any nicotine source - any amount or form (vapor/e-cig/tobacco/patch, gum, etc.)
- Medications that markedly impact glucose metabolism and sleep (insulin, corticosteroids, growth hormone, melatonin)
- Previous or current diagnosis of a clinical eating disorder (e.g., night eating syndrome, anorexia, bulimia, binge eating disorder); or self-report eating disorder behaviors
- Unstable or poorly controlled blood glucose (e.g., hypoglycemia, fasting glucose greater than 125 mg/dL)
- Chronic illness that may be associated with weight change (HIV/AIDS, active cancer, or uncontrolled thyroid disease)
- Shift work
- Recent or upcoming jetlag (travel 3 months prior and during study that is \>1 time zone away from Arizona)
- Current practice of evening and nighttime blue light blocking.
- Poorly controlled hypertension (SBP ≥165 or DBP ≥100)
- Any condition or circumstance that would prevent compliance to the protocol
- Use non-android phone as their primary/personal phone
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALBlue light
Blue light blocking glasses use and discouraged late night eating.
BEHAVIORALEating
Encouraged not to eat past 8pm.
BEHAVIORALStanding
Encouraged to stand for 10 minutes per hour each out from 5pm to bed time.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06963736
Related Trials
RemI for Post-Bariatric Surgery Weight Regain
NCT062929362 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731151 locations
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
NCT0722568637 locations
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459586 locations
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285119 locations